We therefore examined whether VEGFR-2 signaling would be perturbed in tumor vasculature depleted for NRP1 and NRP2 by measuring VEGFR-2 and phosphorylated-VEGFR-2Y1175 localization to endomucin+ vessels. This evidence concerns the gene EMCN and neoplasm.